You are here

Article info

Article menu
Download PDFPDF
Respiratory epidemiology
Original article
Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia

Authors

  • Blánaid M Hicks Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Quebec, Canada PubMed articlesGoogle scholar articles
  • Hui Yin Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada PubMed articlesGoogle scholar articles
  • Franck Bladou Department of Urology, Jewish General Hospital, Montréal, Quebec, Canada Division of Urology, McGill University, Montréal, Quebec, Canada PubMed articlesGoogle scholar articles
  • Pierre Ernst Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada Department of Medicine, McGill University, Montréal, Quebec, Canada PubMed articlesGoogle scholar articles
  • Laurent Azoulay Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Quebec, Canada Gerald Bronfman Department of Oncology, McGill University, Montréal, Quebec, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Laurent Azoulay, Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, 3755 Côte Sainte-Catherine, H-425.1, Montreal, Quebec, Canada H3T 1E2; laurent.azoulay{at}mcgill.ca
View Full Text

Citation

Hicks BM, Yin H, Bladou F, et al
Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia
Thorax 2017;72:596-597.

Publication history

  • Received September 29, 2016
  • Revised November 8, 2016
  • Accepted November 14, 2016
  • First published December 16, 2016.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/